Last Updated: June 9, 2026

Details for New Drug Application (NDA): 212212


✉ Email this page to a colleague

« Back to Dashboard


NDA 212212 describes BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, which is a drug marketed by Teva Pharms Usa Inc and is included in one NDA. It is available from one supplier. Additional details are available on the BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE profile page.

The generic ingredient in BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE is budesonide; formoterol fumarate dihydrate. There are twenty-two drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the budesonide; formoterol fumarate dihydrate profile page.
Pharmacology for NDA: 212212
Suppliers and Packaging for NDA: 212212
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE budesonide; formoterol fumarate dihydrate AEROSOL, METERED;INHALATION 212212 ANDA Teva Pharmaceuticals, Inc. 0480-3080 0480-3080-31 1 POUCH in 1 CARTON (0480-3080-31) / 1 CANISTER in 1 POUCH / 120 AEROSOL, METERED in 1 CANISTER
BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE budesonide; formoterol fumarate dihydrate AEROSOL, METERED;INHALATION 212212 ANDA Teva Pharmaceuticals, Inc. 0480-3081 0480-3081-31 1 POUCH in 1 CARTON (0480-3081-31) / 1 CANISTER in 1 POUCH / 120 AEROSOL, METERED in 1 CANISTER

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:AEROSOL, METERED;INHALATIONStrength0.08MG/INH;0.0045MG/INH
Approval Date:Apr 23, 2026TE:ABRLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:AEROSOL, METERED;INHALATIONStrength0.16MG/INH;0.0045MG/INH
Approval Date:Apr 23, 2026TE:ABRLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.